Phase 1/2 Lupus clinical trials

10 recruiting Phase 1/2 lupus studies in the US. What trial phases mean

Other phases

RecruitingPhase 1 / Phase 2NCT06121297

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

Sponsor: Cabaletta Bio

Orange, CA · Sacramento, CA · New Haven, CT · +18 more sites

RecruitingPhase 1 / Phase 2NCT06434363

Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders

Sponsor: M.D. Anderson Cancer Center

Houston, TX

RecruitingPhase 1 / Phase 2NCT06839976

CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Lupus

Sponsor: Children's Hospital of Philadelphia

Philadelphia, PA

RecruitingPhase 1 / Phase 2NCT06897930

A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE

Sponsor: AstraZeneca

San Francisco, CA · Stanford, CA · Tampa, FL · +13 more sites

RecruitingPhase 1 / Phase 2NCT07800871

FT839 in Autoimmune Diseases

Sponsor: Fate Therapeutics

Fullerton, CA

RecruitingPhase 1 / Phase 2NCT06032923

Double-blind Placebo Controlled Study to Evaluate the Effect of NAD+ Boosting With Nicotinamide Riboside on Immunometabolism and Immunity in Systemic Lupus Erythematosus

Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Bethesda, MD

RecruitingPhase 1 / Phase 2NCT07089121

Descartes-08 for Children, Adolescents, and Young Adults With Autoimmune Disorders

Sponsor: Cartesian Therapeutics

Washington D.C., DC · St Louis, MO · Cincinnati, OH

RecruitingPhase 1 / Phase 2NCT06557265

A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)

Sponsor: Nkarta, Inc.

Little Rock, AR · Tustin, CA · Gainesville, FL · +14 more sites

RecruitingPhase 1 / Phase 2NCT06625671

A Phase 1/2a Study of DB-2304 in Healthy Adults and SLE/CLE Participants

Sponsor: DualityBio Inc.

La Palma, CA · Clearwater, FL · Orlando, FL · +3 more sites

RecruitingPhase 1 / Phase 2NCT05508009

Early Trial of Allogeneic Hematopoietic Stem Cell Transplantation for Patients Who Will Receive a Kidney Transplant From the Same Donor

Sponsor: Alice Bertaina

Palo Alto, CA

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.